Progyny (PGNY) Capital Expenditures (2018 - 2026)

Progyny (PGNY) has reported Capital Expenditures for 9 consecutive years, with $6.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 18.03% year-over-year to $6.2 million in Q2 2026; TTM through Jun 2026 was $22.9 million, a 93.75% increase from a year earlier, with the FY2025 full-year figure at $18.4 million, up 240.61% from the prior year.
• Capital Expenditures was $6.2 million for Q2 2026 at Progyny, down from $6.3 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $6.3 million in Q1 2026 and troughed at $490000.0 in Q2 2022.
• A 5-year average of $2.4 million and a median of $1.2 million in 2022 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures slumped 32.05% in 2024 and jumped 508.43% in 2025, its largest moves.
• Over 5 years, Capital Expenditures stood at $721000.0 in 2022, then dropped by 5.55% to $681000.0 in 2023, then soared by 178.27% to $1.9 million in 2024, then soared by 196.25% to $5.6 million in 2025, then grew by 10.78% to $6.2 million in 2026.
• The last three Capital Expenditures figures came in at $6.2 million (Q2 2026), $6.3 million (Q1 2026), and $5.6 million (Q4 2025), per Business Quant data.